Exodus Point Capital Management, LP Genprex, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.82 - $3.5 $21,658 - $41,650	-11,900 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.21 - $2.7 $14,399 - $32,130	11,900 New	11,900 $16,000
Q3 2021 Nov 15, 2021	SELL	$2.59 - $3.36 $66,635 - $86,446	-25,728 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.11 - $4.87 $80,014 - $125,295	25,728 New	25,728 $86,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $88.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.